Teratogenic effect of rubella virus.
D000015:Abnormalities, Multiple / Q000209:etiology; D000906:Antibodies / Q000032:analysis; D000013:Congenital Abnormalities / Q000209:etiology*; D046508:Culture Techniques; D003638:Deafness / Q000209:etiology; D005124:Eye Abnormalities; D005260:Female; D005455:Fluorescent Antibody Technique; D006330:Heart Defects, Congenital / Q000209:etiology; D006385:Hemagglutination Inhibition Tests; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D007231:Infant, Newborn; D008431:Maternal-Fetal Exchange; D009500:Neutralization Tests; D009924:Organ Culture Techniques; D010920:Placenta / Q000473:pathology; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious; D012409:Rubella / Q000150:complications* / Q000151:congenital / Q000276:immunology / Q000503:physiopathology; D012412:Rubella virus / Q000302:isolation & purification; D014357:Trypsin; D014776:Virus Cultivation
D000906:Antibodies; D007136:Immunoglobulins; D014357:Trypsin